Welcome
This site is intended to provide online access to current, accurate, and unbiased scientific information about our products.
The medical information contained on this website focuses on topics on products in the anti-infective, psychiatry, cardiovascular, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, urology and virology fields. Below are some of our main products.
- ACIPHEX® (rabeprazole sodium)
- AXERT® (almotriptan malate)
- CONCERTA® (methylphenidate HCl) includes Boxed Warning
- DORIBAX® (doripenem for injection)
- DOXIL® (doxorubicin HCl liposome injection) includes Boxed Warning
- EDURANT™ (Rilpivirine)
- ELMIRON® (pentosan polysulfat sodium)
- FLEXERIL® (cyclobenzaprine HCl)
- HALDOL® (haloperidol) includes Boxed Warning
- HALDOL® Decanoate (haloperidol) includes Boxed Warning
- INTELENCE® (etravirine)
- INVEGA® (paliperidone) includes Boxed Warning
- INVEGA® SUSTENNA® (paliperidone palmitate) includes Boxed Warning
- LEVAQUIN® (levofloxacin) includes Boxed Warning
- NATRECOR® (nesiritide)
- NUCYNTA® (tapentadol)
- NUCYNTA ER ® (tapentadol)
- PANCREAZE®(pancrelipase)
- PREZISTA®(darunavir)
- PROCRIT® (epoetin alfa) includes Boxed Warning
- RAZADYNE® ER AND RAZADYNE® (galantamine HBr)
- REMICADE® (infliximab) includes Boxed Warning
- RISPERDAL® (risperidone) includes Boxed Warning
- RISPERDAL® CONSTA® (risperidone) includes Boxed Warning
- SIMPONI®(golimumab) includes Boxed Warning
- STELARA® (ustekinumab)
- TOPAMAX® (topiramate)
- ULTRAM® (tramadol hydrochloride)
- ULTRAM® ER (tramadol hydrochloride)
- XARELTO® (rivaroxaban tablets)
- ZYTIGA® (Abiraterone Acetate)
02/27/12
RISPERDAL CONSTA (risperidone) Long-Acting Injection Dear Healthcare Professional Letter
02/24/12
LEVAQUIN (levofloxacin) Dear Healthcare Professional Letter
01/03/12
DORIBAX (doripenem for injection) Dear Healthcare Professional Letter
12/12/11
Oncology - DOXIL® (doxorubicin HCl liposome injection) – Supply Shortage Update
11/21/11
Oncology - DOXIL® (doxorubicin HCl liposome injection) – Supply Shortage Update
11/04/11
Cardiovascular - XARELTO® (rivaroxaban) New Indication Approval
06/24/11
Oncology/Nephrology - PROCRIT® (epoetin alfa) - ESA label update
06/21/11
Oncology - DOXIL® (doxorubicin HCl liposome injection) – Availability
06/16/11
Psychiatry – RISPERDAL® (risperidone)/Risperidone - Recall
04/11/11
Oncology/Nephrology – PROCRIT®(epoetin alfa) - Recall
Access comprehensive information on Risk Evaluation and Mitigation Strategies (REMS) for our products. A REMS is a strategy to manage a known or a potential serious risk associated with a drug or biological product.
Click on the product below for more information.
Outcomes Tools
Access tools that may be utilized as an aid to understand current utilization patterns or as part of assessing quality improvement opportunities. Links to available software programs that may be downloaded for your use are available by selecting the therapeutic area of interest below:
Clinical Tools
Access tools to help improve patient care. Links to tools are available by selecting the therapeutic area of interest below.
Coming Soon!
Patient Assistance Program
Provides access to a variety of patient assistance programs that offer more than 1000 prescription medications and medical products for free or at a discount to those who qualify.
Contact Us
-
Call us at 1-800-JANSSEN
(1-800-526-7736)to speak to a clinical expert regarding your question or to report a possible adverse event or product quality complaint.
-
COMING SOON!
Connect Online
to receive answers to questions and real-time presentations from a clinical expert.
-
Submit a Question
via this web site